Skip to evidence report

MAC.proliferating.DNA_replication: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 834 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for MAC.proliferating.DNA_replication
#Trait / studyIndividual trait IDMean IC score
1Recent trouble relaxing | AnxietyUKBB0000074555.87
2CD83/TREM2 ratioGCST9031390855.18
3CTSO/IGF2R ratioGCST9031431753.83
4MARCO levelsGCST9046986153.13
5APCS levelsGCST9046832852.81
6PTPRZ1 levelsGCST9047038851.60
7TREM2 levelsGCST9047096046.35
8ALCAM/LRRC25 ratioGCST9031323945.07
9FOLR2/THY1 ratioGCST9031486743.52
10Degree of unsaturationGCST9050274642.58
11T1 FreeSurfer DKT rh lateraloccipital areaGCST9038429542.30
12CD300C/FOLR2 ratioGCST9031378742.01
13GLB1/PCSK9 ratioGCST9031493341.48
14CFI levelsGCST9046873040.82
15FOLR3 levelsGCST9046926140.16
16HAVCR2/TREM2 ratioGCST9031503140.07
17CD40LG/EREG ratioGCST9031382039.68
18CD300C/LRRC25 ratioGCST9031379039.59
19LRRC25 levelsGCST9046980139.21
20HPCAL1/PMVK ratioGCST9031507638.85
21T1 FreeSurfer DK rh lateraloccipital areaGCST9038569938.03
22FOLR2/HAVCR2 ratioGCST9031486537.30
23Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levelsGCST9006025437.28
24Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levelsGCST9020009837.11
25Monounsaturated fatty acid levelsGCST9050203837.09
26MELTF levelsGCST9046988537.05
27UFC1 levelsGCST9024324536.27
28Recent feelings of tiredness or low energy | DepressionUKBB0000074036.11
29PIK3IP1/TNFRSF1A ratioGCST9031565335.97
30IFIT2 levelsGCST9009086435.95
31CALCOCO1/CASP3 ratioGCST9031359635.92
32EREG/MPIG6B ratioGCST9031470435.77
33CES2 levelsGCST9046871935.62
34ADGRE2/B4GALT1 ratioGCST9031317435.31
35Type 2 diabetesGCST9008607235.00
36MMP12 levelsGCST9046991634.49
37Cholesterol_[M+H-H2O]1+ levelsGCST9006013334.18
38CDCP1 levelsGCST9046866734.11
39ITGA5 levelsGCST9046963533.68
40Free cholesterol in very large HDLGCST9050038333.19
41MRC1 levelsGCST9046993933.18
42ADA2/COMP ratioGCST9031316633.16
43Triacylglycerol_58:7_[M+NH4]1+ levelsGCST9006056432.89
44CASP3/LYN ratioGCST9031363532.85
45HGF/MMP8 ratioGCST9031505532.69
46Phospholipids in large LDLGCST9049804932.50
47Total fatty acid levelsGCST9050222032.32
48LRG1 levelsGCST9046979332.28
49Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST9009304532.16
50PSRC1/SORT1 ratioGCST9031574232.04
51Recent inability to stop or control worrying | AnxietyUKBB0000074231.58
52GAS6/NOTCH1 ratioGCST9031491831.58
53MFGE8 levelsGCST9046990031.56
54CD59/SCARB2 ratioGCST9031385931.43
55LTBP2/PDGFRA ratioGCST9031533831.40
56PLAUR/TREM2 ratioGCST9031567630.72
57SERPIND1 levelsGCST9047059530.57
58GAS6 levelsGCST9046930530.42
59C1QA levelsGCST9046848530.39
60Triglyceride levels in chylomicrons and extremely large VLDLGCST9050107530.35
61Phospholipids in very large HDLGCST9050045130.04
62CPB2 levelsGCST9046884030.03
63Monounsaturated fatty acid levelsGCST9050236230.00
64CHIT1 levelsGCST9046874429.83
65APOA2 levelsGCST9046833229.69
66ADGRE2/IFNGR1 ratioGCST9031317729.57
67SERPING1 levelsGCST9047060029.36
68Plasma 4-guanidinobutanoate levels in chronic kidney diseaseGCST9026462029.32
69CRHBP/TREM2 ratioGCST9031426029.22
70CD83 levelsGCST9046865229.07
71ITIH3/VCAM1 ratioGCST9031523629.02
72Triglycerides to Total Lipids in Very Large HDL percentageGCST9050050629.02
73ITGB5/S100A4 ratioGCST9031523328.99
74Phospholipids to Total Lipids in Large HDL percentageGCST9049786828.87
75Total fatty acid levelsGCST9050272728.84
76PRCP levelsGCST9047031428.78
77ADA2/VCAM1 ratioGCST9031316728.73
78PIK3IP1/TNFRSF1B ratioGCST9031565428.66
79CD300E/LILRA5 ratioGCST9031379828.59
80T1 FreeSurfer BA lh BA3a exvivo thicknessGCST9038552128.54
81ERBB3 levelsGCST9046914028.28
82FABP4/SNCG ratioGCST9031475928.03
83Total Lipids in HDLGCST9049740127.97
84MANF/NCK2 ratioGCST9031535927.92
85CD300C/HAVCR2 ratioGCST9031378927.69
86Average diameter for HDL particlesGCST9049744627.62
87Triacylglycerol (52:4) [NL-16:0] levelsGCST9002517027.59
88Triglycerides x anxiety interaction (2df test)GCST9057067727.51
89HMOX1 levelsGCST9046946527.17
90PLG levelsGCST9047025727.14
91SIGLEC5 levelsGCST9047063327.07
92IDP dMRI ProbtrackX ISOVF atr lGCST9000452727.06
93CPVL levelsGCST9046884827.04
94GFRA2 levelsGCST9046932927.03
95CTSL levelsGCST9046891426.92
96NPY/SMOC1 ratioGCST9031555126.85
97DAPK2 levelsGCST9046894526.83
98Cholesterol to Total Lipids in Small HDL percentageGCST9049936926.81
99CDCP1/MSR1 ratioGCST9031393826.80
100PAPPA levelsGCST9047015726.78
101Free Cholesterol to Total Lipids in Medium HDL percentageGCST9049858326.69
102LILRB2 levelsGCST9046977726.63
103MPHOSPH8/PSRC1 ratioGCST9031547826.51
104Cholesteryl Esters to Total Lipids in Small HDL percentageGCST9049940326.49
105Cholesteryl esters in small HDL (UKB data field 23576)GCST9026967326.46
106CD83/HAVCR2 ratioGCST9031390426.40
107CLEC4A levelsGCST9046877126.33
108Triglyceride levels in chylomicrons and extremely large VLDLGCST9050106826.30
109Free cholesterol in small HDL (UKB data field 23577)GCST9026967426.01
110TIMD4 levelsGCST9047086625.97
111Free Cholesterol in HDLGCST9049737925.76
112TEK levelsGCST9047082925.70
113FOLR2/MSR1 ratioGCST9031486625.67
114CTSL levelsGCST9001207325.67
115KLK7 levelsGCST9046970625.62
116CTSO levelsGCST9046891525.43
117Triglyceride levels in chylomicrons and extremely large VLDLGCST9013263025.29
118Triglyceride levels in very large HDLGCST9013263625.26
119Ulcerative colitis (strict) with PSCFING0000138925.21
120SIGLEC10 levelsGCST9047063025.19
121Phospholipids in HDLGCST9049743025.19
122Cholesterol in small HDL (UKB data field 23575)GCST9026967225.10
123Omega-3 fatty acids to total fatty acids percentageGCST9050208725.10
124CD300LG/TNFRSF1A ratioGCST9031380325.01
125Total lipids in large HDLGCST9049781824.98
126Recent worrying too much about different things | AnxietyUKBB0000074624.93
127Average diameter for VLDL particlesGCST9009300224.92
128Cholesteryl ester levels in small HDLGCST9009294624.88
129Total concentration of lipoprotein particles (UKB data field 23427)GCST9026952424.76
130APOA1 levelsGCST9049711924.74
131CD300C/NBL1 ratioGCST9031379224.74
132MMP9/PLTP ratioGCST9031547124.72
133aparc-a2009s rh volume G+S-subcentralGCST9000300224.64
134ADGRE1 levelsGCST9046823624.61
135FIS1/HSPA1A ratioGCST9031482524.58
136Phospholipids to total lipids ratio in chylomicrons and extremely large VLDLGCST9009304924.57
137Free cholesterol in small HDLGCST9049942524.54
138Average diameter for VLDL particles (UKB data field 23431)GCST9026952824.50
139CD164/LGMN ratioGCST9031374124.44
140AXL/CD163 ratioGCST9031341824.44
141CTSD levelsGCST9046891024.39
142Concentration of large HDL particlesGCST9049783624.34
143CD99/RELT ratioGCST9031393024.29
144LRIG1 levelsGCST9046979424.25
145Concentration of small HDL particlesGCST9049946124.23
146Total cholines levelsGCST9049718324.21
147GBA1 levelsGCST9042326224.19
148Free cholesterol in HDL (UKB data field 23422)GCST9026951924.18
149PDGFB/PTPN6 ratioGCST9031562524.12
150Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST9026432924.10
151Concentration of HDL particles (UKB data field 23430)GCST9026952724.05
152Free cholesterol levels in chylomicrons and extremely large VLDLGCST9050096524.02
153X-13671 levelsGCST9024382923.97
154Other bacterial diseasesFING0000096823.93
155Average diameter for LDL particlesGCST9049845823.78
156CALCOCO1/VPS53 ratioGCST9031361223.75
157Free cholesterol levels in HDLGCST9009282423.66
158AXL/MSR1 ratioGCST9031342223.55
159Concentration of HDL particlesGCST9049741423.54
160FURIN levelsGCST9046927723.50
161ATP5IF1/FIS1 ratioGCST9031338523.42
162FOLR2 levelsGCST9046926023.40
163Triglyceride levels in large HDLGCST9009285423.39
164Polyunsaturated fatty acids to total fatty acids percentageGCST9049930223.14
165HDL cholesterolGCST00222323.13
166LTB4R levelsGCST9042216423.11
167Triglyceride levels in very large HDLGCST9009301423.09
168Total concentration of lipoprotein particlesGCST9050010123.09
169F9 levelsGCST9046917223.06
170Cholesterol levels in chylomicrons and extremely large VLDLGCST9050090522.95
171DNAJA2/PRDX5 ratioGCST9031450622.91
172FAS levelsGCST9009070122.87
173Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582)GCST9026967922.84
174ALB levelsGCST9047510622.76
175Phospholipids to Total Lipids in Very Large HDL percentageGCST9050047222.71
176CD163/MSR1 ratioGCST9031373822.69
177Free cholesterol levels in chylomicrons and extremely large VLDLGCST9050097522.67
178Sleep durationGCST00383922.63
179Saturated fatty acids levelsGCST9050267522.60
180HDL cholesterol levelsGCST9049734022.58
181MANSC4 levelsGCST9046984822.55
182MMP9/OLR1 ratioGCST9031546722.55
183Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levelsGCST9006055722.54
184Radial styloid tenosynovitis [de Quervain]FING0000123722.54
185PLA2G7 levelsGCST9047024922.52
186Total lipids in HDL (UKB data field 23426)GCST9026952322.47
187CD300E/CD59 ratioGCST9031379422.47
188Phosphoglycerides levelsGCST9049926522.44
189Triglycerides to Total Lipids in Medium LDL percentageGCST9049888522.39
190Haematocrit percentage (UKB data field 30030)GCST9046807322.25
191Linoleic acid to total fatty acids percentageGCST9049832122.23
192ITGA5/VCAM1 ratioGCST9031520622.17
193Parkinson's disease or first degree relation to individual with Parkinson's diseaseGCST00932522.15
194Free cholesterol in medium HDL (UKB data field 23570)GCST9026966722.14
195CLUL1 levelsGCST9046879222.10
196BTN2A1/CSF1 ratioGCST9031354122.10
197BTN2A1/SIGLEC1 ratioGCST9031354822.09
198CD33 levelsGCST9046862522.05
199ALCAM levelsGCST9046827922.01
200Hands-free device/speakerphone use with mobile phone in last 3 month | Electronic device useUKBB0000030421.95
201IGF2R/RNASET2 ratioGCST9031513221.92
202Docosahexaenoic acid levelsGCST9049725621.91
203Heart rate variability (corrected standard deviation of normal-to-normal intervals)GCST9028126621.88
204TriglyceridesGCST00221621.85
205Concentration of small HDL particles (UKB data field 23572)GCST9026966921.83
206Polyunsaturated fatty acid levelsGCST9050260621.81
207Linoleic acid levelsGCST9050229421.80
208APCS levelsGCST9042846321.80
209Phosphatidylcholine levelsGCST9049924821.80
210Concentration of medium HDL particlesGCST9049861721.76
211MARCO/SIGLEC1 ratioGCST9031538721.75
212Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050207421.74
213GALNT7 levelsGCST9046929921.66
214HDL cholesterolGCST9001873621.51
215Triglycerides in large VLDL (UKB data field 23501)GCST9026959821.44
216Triglyceride levels in large VLDLGCST9009287821.42
217CCL27 levelsGCST9046857921.38
218Free cholesterol levels in small HDLGCST9009294821.38
219PMVK/PRDX5 ratioGCST9031569421.37
220Monounsaturated fatty acid levelsGCST9050236321.35
221Phospholipids in large VLDLGCST9049824721.30
222ARTN levelsGCST9046837221.29
223Phosphatidylcholines levels (UKB data field 23437)GCST9026953421.28
224Average diameter for VLDL particlesGCST9050029021.18
225Linoleic acid levelsGCST9009288021.14
226HDL cholesterol | Blood biochemistryUKBB0000030621.11
227Total esterified cholesterol levelsGCST9050003621.07
228Concentration of large HDL particlesGCST9009285121.06
229Phospholipids in small LDLGCST9049967321.06
230Clonal hematopoiesis (large clone)GCST9010262121.04
231Cholesterol to Total Lipids in Medium HDL percentageGCST9049851921.03
232Average diameter for HDL particlesGCST9009282821.02
233Free Cholesterol to Total Lipids in Small HDL percentageGCST9049943120.97
234AXL levelsGCST9046840620.96
235Total lipids in large HDL (UKB data field 23559)GCST9026965620.95
236PECAM1/SOD2 ratioGCST9031564720.91
237Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney diseaseGCST9026479620.83
238Diacylglycerol_36:2_[M+H-H2O]1+ levelsGCST9006019120.83
239Phospholipid levels in very large HDLGCST9013264220.82
240DNAJA2/FIS1 ratioGCST9031450120.81
241PLTP levelsGCST9047026220.78
242Free cholesterol levels in very large HDLGCST9013268020.75
243Free Cholesterol in HDLGCST9049738120.74
244APOA1 levelsGCST9026953720.70
245Cholesteryl esters to total lipids ratio in large LDLGCST9009285920.69
246Concentration of large HDL particles (UKB data field 23558)GCST9026965520.69
247Free cholesterol levels in very large HDLGCST9009300820.59
248Phospholipid levels in very large HDLGCST9009301220.57
249Triglycerides x depression interaction (2df test)GCST9057067920.54
250Free cholesterol in medium HDLGCST9049856320.52
251Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levelsGCST9020010320.50
252ADGRE5/NOTCH1 ratioGCST9031318120.47
253Liver condition (ex. cirrhosis)GCST9047527020.47
254Total concentration of lipoprotein particlesGCST9009299020.46
255Osteoporosis, osteopenia and pathological fracture | musculoskeletalUKBB0000060020.45
256Total lipids in very large HDLGCST9050042320.41
257SIGLEC8 levelsGCST9008988620.40
258SCARB2 levelsGCST9047053520.40
259CTSC levelsGCST9046890920.39
260ADGRE5/VCAM1 ratioGCST9031318420.39
261Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050215520.38
262CCL17/F2R ratioGCST9031368620.32
263Average diameter for VLDL particlesGCST9050027920.30
264Cholesterol levels in small HDLGCST9009294420.23
265EGFLAM levelsGCST9042165120.16
266GSTA1/PBLD ratioGCST9031499420.15
267Triglyceride levelsGCST9023966320.15
268CD69/SNAP29 ratioGCST9031388720.13
269Free Cholesterol to Total Lipids in Large HDL percentageGCST9049779020.13
270Free cholesterol in large HDLGCST9049778620.13
2711-stearoyl-gpc (18:0) levelsGCST9019973220.12
272Triglycerides to Total Lipids in Large HDL percentageGCST9049789620.03
273Monounsaturated fatty acids to total fatty acids percentageGCST9050205119.97
274Free cholesterol to total lipids ratio in large HDLGCST9009284919.96
275Positional arithmetic | Fluid intelligence / reasoningUKBB0000065419.95
276Phospholipids in HDL (UKB data field 23414)GCST9026951119.89
277Triacylglycerol_56:7_[M+NH4]1+ levelsGCST9006055119.87
278Concentration of very large HDL particlesGCST9050043119.84
279Free cholesterol levels in large HDLGCST9009284819.84
280HyperlipidemiaGCST9009099419.83
281ADH4/DCXR ratioGCST9031319019.81
282HDL cholesterol levels (UKB data field 23406)GCST9026950319.81
283Monounsaturated fatty acid levelsGCST9050234619.79
284Phosphatidylcholine levelsGCST9009293719.76
285Concentration of small HDL particlesGCST9009295119.76
286Total lipid levels in HDLGCST9009282519.75
287Average diameter for HDL particles (UKB data field 23433)GCST9026953019.75
288Free cholesterol in medium VLDLGCST9049896519.73
289Phospholipids to total lipids ratio in large LDLGCST9009286519.72
290T1 FreeSurfer a2009s lh S central thicknessGCST9038478619.71
291Cholesterol in Medium LDLGCST9049870319.70
292Docosahexaenoic acid to total fatty acids percentageGCST9050199719.69
293Social trust (aggregated)GCST9031931519.66
294Total lipid levels in large HDLGCST9009285019.66
295Concentration of HDL particlesGCST9009282619.65
296Linoleic acid levelsGCST9050200419.64
297LDLR levelsGCST9046975019.64
298Omega-3 fatty acids to total fatty acids percentageGCST9050246019.63
299Phospholipids in large HDL (UKB data field 23560)GCST9026965719.59
300Phosphoglycerides levels (UKB data field 23434)GCST9026953119.59
301ATF6 levelsGCST9061726019.57
302Total lipid levels in lipoprotein particlesGCST9050008519.53
303FAM20A levelsGCST9046918519.53
304Phospholipid levels in large HDLGCST9009285219.51
305Concentration of very large HDL particlesGCST9009301119.50
306CD163 levelsGCST9046860019.46
307Chronic bronchitis | respiratoryUKBB0000013619.46
308Total cholesterol levelsGCST9050001519.44
309MERTK levelsGCST9046989019.44
310APOA levelsGCST9046806119.44
311Free cholesterol in very large VLDLGCST9050058119.37
312MSRA/SNAP29 ratioGCST9031550019.36
313Parental longevity (both parents in top 10%)GCST00669819.34
314Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST9049855019.33
315LRP1 levelsGCST9046979719.32
316Cholesteryl Esters in Large VLDLGCST9049814619.31
317ACY1/GSTA1 ratioGCST9031316319.31
318NRP2 levelsGCST9047008619.27
319Free cholesterol in very large VLDLGCST9050057519.26
320Total cholines levels (UKB data field 23436)GCST9026953319.26
321IGF2R levelsGCST9046952619.26
322Triacylglycerol_56:6_[M+NH4]1+ levelsGCST9006055319.25
323Cholesterol in Large LDLGCST9049791919.24
324SOD2 levelsGCST9047070519.23
325LILRA2 levelsGCST9046977119.22
326Total fatty acid levelsGCST9050272619.11
327Cholesteryl Esters in HDLGCST9049735719.11
328Sleep disorders | neurologicalUKBB0000077619.11
329LAT2/MANF ratioGCST9031527719.10
330Phospholipids in medium VLDLGCST9049902419.04
331GPNMB levelsGCST9046939319.04
332Concentration of HDL particlesGCST9049740619.03
333High density lipoprotein cholesterol levelsGCST9027863519.01
334Metabolic syndromeGCST9044448918.98
335ITGB1 levelsGCST9046964318.95
336Free cholesterol to total lipids ratio in very large HDLGCST9009300918.89
337Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levelsGCST9006014818.88
338Cholesteryl Esters in Large LDLGCST9049794918.87
339T1 FreeSurfer a2009s lh G precentral volumeGCST9038484418.86
340CD1C levelsGCST9046860418.86
341Phospholipids in medium LDLGCST9049883118.85
342Phosphoglycerides levelsGCST9009293818.82
343VCAM1 levelsGCST9047103118.82
344AXIN1/CALCOCO1 ratioGCST9031340218.79
345NRCAM/NTRK2 ratioGCST9031555218.78
346Average diameter for LDL particlesGCST9049845718.76
347NPTX2 levelsGCST9047007918.75
348Total lipid levels in very large HDLGCST9009301018.74
349Total cholines levelsGCST9009281218.73
350CD163/MARCO ratioGCST9031373718.72
351Free cholesterol in medium HDLGCST9049856218.70
352Omega-3 fatty acid levelsGCST9050206218.70
353Polyunsaturated fatty acid levelsGCST9050261818.70
354Omega-3 fatty acid levelsGCST9050205618.69
355Free cholesterol in large HDL (UKB data field 23563)GCST9026966018.61
356wg rh intensity-contrast parahippocampalGCST9000384218.59
357Phospholipids to total lipids in IDL percentage (UKB data field 23609)GCST9026970618.58
358RRM2 levelsGCST9047050118.58
359CD300A levelsGCST9046861918.58
360Hard cheese likingGCST9009477818.55
361C2/LILRB4 ratioGCST9031355418.51
362Triacylglycerol_56:5_[M+NH4]1+ levelsGCST9006055418.48
363Linoleic acid levelsGCST9050230618.46
364Cholesterol levels in very large HDLGCST9009300418.46
365Triglyceride levels in medium VLDLGCST9009292618.46
366CCN2/TPP1 ratioGCST9031371818.45
367METAP2/RILP ratioGCST9031543318.42
368NeuroticismGCST00292018.41
369Triglyceride to HDL cholesterol ratioGCST9029595018.40
370Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06)GCST9029158218.39
371Blood cell traits latent factor 7 (white cell)GCST9055924918.37
372Total phospholipid levels in lipoprotein particlesGCST9050012418.34
373ITGA2 levelsGCST9046963418.32
374APOD levelsGCST9046833718.30
375Docosahexaenoic acid to total fatty acids percentageGCST9050228118.29
376Sleep disorders | Episodic and paroxysmal disordersUKBB0000077518.26
377MAD1L1/POLR2F ratioGCST9031535418.26
378Degree of unsaturationGCST9050223018.24
379Cholesterol to Total Lipids in Large HDL percentageGCST9049773218.24
380Concentration of large HDL particlesGCST9049782818.24
381Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levelsGCST9020011818.22
382Fruit juice likingGCST9009476818.21
383NCS1 levelsGCST9047001118.17
384Cholesterol in large HDL (UKB data field 23561)GCST9026965818.17
385Total fatty acid levelsGCST9050271018.14
386PSAP levelsGCST9047035118.13
387THPO levelsGCST9047085718.13
388Saturated fatty acids levelsGCST9050265818.11
389APOA levelsUKBB0000004018.01
390MSR1 levelsGCST9046995017.96
391Sphingomyelins levelsGCST9049998317.94
392Total lipid levels in large VLDLGCST9009287417.93
393Triglycerides to Total Lipids in Medium LDL percentageGCST9049888117.92
394KAZALD1 levelsGCST9046966517.92
395FN1 levelsGCST9046925517.92
396Total lipids in large HDLGCST9049781517.91
397Linoleic acid levels (UKB data field 23449)GCST9026954617.89
398SUSD1/THPO ratioGCST9031589917.88
399NRCAM levelsGCST9047008217.88
400Omega-6 fatty acids to total fatty acids percentageGCST9049921017.80
401Total lipids in very small VLDLGCST9050081317.79
402Concentration of large VLDL particlesGCST9009287517.79
403ARHGEF12/DECR1 ratioGCST9031334917.79
404IDP dMRI TBSS L1 Cingulum cingulate gyrus RGCST9000410917.76
405Concentration of very large HDL particlesGCST9050043617.76
406CD5/IL16 ratioGCST9031386117.75
407Cholesterol levels in large HDLGCST9009284417.71
408Total lipids in small HDL (UKB data field 23573)GCST9026967017.69
409Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney diseaseGCST9026420717.68
410MXRA8 levelsGCST9046996817.68
411Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST9050037317.67
412B4GAT1 levelsGCST9046841317.67
413AGR3 levelsGCST9046825417.67
4141-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levelsGCST9019964917.63
415CRADD/DARS1 ratioGCST9031423417.61
416Free cholesterol levels in medium HDLGCST9009289617.60
417Cholesteryl ester levels in very large HDLGCST9009300617.59
418Monounsaturated fatty acid levelsGCST9050235817.59
419Dermatophytosis of nail (PheCode 110.11)GCST9047556217.59
420Average diameter for HDL particlesGCST9013270217.57
421COMP/ITGAV ratioGCST9031419017.56
422Free Cholesterol to Total Lipids in Large HDL percentageGCST9049779317.55
423Cholesteryl Esters to Total Lipids in Large HDL percentageGCST9049776817.53
424Total concentration of lipoprotein particlesGCST9050010317.52
425Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST9050079117.48
426APOA1 levelsGCST9009280817.47
427OLR1/OSM ratioGCST9031558317.46
428ROBO1 levelsGCST9047048917.43
429Triglycerides in medium VLDLGCST9049906517.39
430Total lipids in medium HDLGCST9049859717.37
431SIGLEC1 levelsGCST9047063217.37
432TriglyceridesGCST00075817.32
433Phospholipids to Total Lipids in Large HDL percentageGCST9049786317.31
434Free Cholesterol to Total Lipids in Very Large HDL percentageGCST9050039717.30
435MEGF9 levelsGCST9046988417.27
436High density lipoprotein cholesterol levelsGCST9023965117.27
437CLPP levelsGCST9046878517.25
438Saturated fatty acids levelsGCST9050219417.22
439Cholesteryl esters in HDL (UKB data field 23418)GCST9026951517.20
440Triglycerides in medium VLDL (UKB data field 23508)GCST9026960517.19
441Free Cholesterol to Total Lipids in Medium HDL percentageGCST9049858017.18
442ADGRE2/CD58 ratioGCST9031317517.18
443HEG1 levelsGCST9046944417.18
444MAN1A2 levelsGCST9046984317.17
445IGF2R/LGMN ratioGCST9031513117.15
446Glycoprotein acetyls levelsGCST9049732017.15
447APOM levelsGCST9046834217.14
448Cholesteryl Esters in Small LDLGCST9049958617.13
449Sleep apnea | neurologicalUKBB0000077417.12
450Cholesteryl esters in large HDL (UKB data field 23562)GCST9026965917.08
451Cholesterol to Total Lipids in Very Large HDL percentageGCST9050033317.06
452CD164/CD99 ratioGCST9031374017.06
453Triglycerides in large LDLGCST9049808317.06
454C36:4 Phosphatidylethanolamine levels in chronic kidney diseaseGCST9025735717.02
455Cholesteryl ester levels in large HDLGCST9009284616.99
456NUDT5/RWDD1 ratioGCST9031558016.98
457Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)GCST9026972916.97
458Plasma methylsuccinoylcarnitine levels in chronic kidney diseaseGCST9026550816.97
459Job involves shift work | EmploymentUKBB0000038516.97
460APOA1 levelsGCST9049712216.95
461CPM/PCSK9 ratioGCST9031421616.95
462Phospholipids to total lipids ratio in large HDLGCST9009285316.94
463Triglycerides to Total Lipids in Large VLDL percentageGCST9049828716.90
464Cholesterol in Medium VLDLGCST9049890316.89
465Omega-3 fatty acid levelsGCST9050243716.87
466Cholesterol to Total Lipids in Very Small VLDL percentageGCST9050071616.87
467Triglycerides to Total Lipids in Large VLDL percentageGCST9049829316.85
468Omega-3 fatty acid levelsGCST9050206116.84
469ALB levelsGCST9002599216.79
470Triglyceride levels in small VLDLGCST9009297816.77
471Triglycerides in very large VLDLGCST9050067116.75
472LILRA5 levelsGCST9046977416.74
473HDL cholesterolGCST00075516.73
474Triglycerides in LDLGCST9049846916.73
475Triacylglycerol (54:2) [NL-18:0] levelsGCST9002517516.73
476Triglycerides in large VLDLGCST9049826716.71
477Phospholipids in medium LDLGCST9049883216.71
478Phospholipids to Total Lipids in Very Small VLDL percentageGCST9050086616.71
479Phospholipid levels in HDLGCST9009282716.70
480Diacylglycerol_36:1_[M+H-H2O]1+ levelsGCST9006019316.63
481CC2D1A/CRADD ratioGCST9031366316.62
482Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642)GCST9026973916.62
483ITIH3 levelsGCST9046965016.61
484ADGRE5/GAS6 ratioGCST9031317916.60
485Saturated fatty acids to total fatty acids percentageGCST9049996616.59
486Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)FING0000086616.56
487Total Lipids in HDLGCST9049739316.55
488Cholesterol to Total Lipids in Medium LDL percentageGCST9049871416.54
489Cholesteryl ester_18:2_[M+NH4]1+ levelsGCST9006022016.54
490Concentration of medium HDL particles (UKB data field 23565)GCST9026966216.52
491GRSF1 levelsGCST9046940716.51
492Familial combined hyperlipidemia defined by Brunzell criteriaGCST9010400316.51
493Total lipids in medium HDL (UKB data field 23566)GCST9026966316.48
494ALB levelsGCST9047510316.46
495Phospholipids to total lipids ratio in IDLGCST9009284016.34
496Docosahexaenoic acid levelsGCST9050198416.34
497Triglycerides in large HDLGCST9049788216.33
498Alkenylphosphatidylethanolamine (P-20:0/18:2) levelsGCST9002568316.32
499Omega-6 fatty acid levelsGCST9050250216.32
500Monounsaturated fatty acids to total fatty acids percentageGCST9050238816.31
501ALB levelsGCST9049710816.31
502Phospholipid levels in chylomicrons and extremely large VLDLGCST9050104216.29
503CCL24 levelsGCST9046857616.28
504Treatment or medication use - ezetimibe (UKB data field 20003_1141192736)GCST9004254116.27
505CDKN1A/DAB2 ratioGCST9031396716.26
506CA4/FOLR2 ratioGCST9031358516.25
507Free cholesterol to total lipids ratio in IDLGCST9009283616.25
508DKK1/PTPN6 ratioGCST9031447816.24
509Polyunsaturated fatty acid levelsGCST9050213416.23
510Total lipid levels in very large VLDLGCST9009302216.21
511Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levelsGCST9006039516.21
512Total fatty acid levelsGCST9050006116.20
513ALB levelsUKBB0000001916.20
514Total lipids in large VLDL (UKB data field 23496)GCST9026959316.18
515Triglycerides in LDLGCST9049847216.16
516CTSB levelsGCST9046890816.13
517HPCAL1/SERPINB9 ratioGCST9031507916.11
518Phospholipids to total lipids in large LDL percentage (UKB data field 23614)GCST9026971116.10
519COMP/DPP4 ratioGCST9031418816.10
5203-Hydroxybutyrate levelsGCST9009281116.08
521Free Cholesterol to Total Lipids in Very Large HDL percentageGCST9050039816.05
522HDL cholesterol levelsGCST9049735216.04
523Phospholipid levels in large VLDLGCST9009287616.04
524DCXR/GSTA1 ratioGCST9031443716.02
525B3GNT7 levelsGCST9046841116.00
526Membranous nephropathyGCST01000616.00
527IDP SWI T2star left pallidumGCST9000386915.99
528CD69/NFATC1 ratioGCST9031387915.97
529EIF3J levelsGCST9024112215.95
530Superficial cellulitis and abscess (PheCode 681)GCST9047616515.93
531CD207 levelsGCST9046860715.91
532Triglyceride levels in very large VLDLGCST9009302615.90
533APOM/MCAM ratioGCST9031331515.89
534High-density lipoprotein levels (MTAG)GCST9017914715.88
535Cholesteryl Esters in Medium VLDLGCST9049893915.88
536Total lipids in very large HDLGCST9050041015.88
537Cholesterol to Total Lipids in Large HDL percentageGCST9049773015.87
538Cholesterol to total lipids ratio in medium VLDLGCST9009291715.84
539PLA2G15/PRCP ratioGCST9031566115.83
540Concentration of large VLDL particlesGCST9049822315.82
541EREG/GYS1 ratioGCST9031470115.81
542Cholesteryl Esters to Total Lipids in Small HDL percentageGCST9049940615.81
543Familial combined hyperlipidemia defined by Dutch criteriaGCST9010400515.81
544Linoleic acid levelsGCST9050201215.79
545MMP9/OSM ratioGCST9031546815.78
546Cholesterol levels in chylomicrons and extremely large VLDLGCST9050091815.78
547Reason for reducing amount of alcohol drunk - Health precaution | AlcoholUKBB0000073415.77
548Monounsaturated fatty acids to total fatty acids percentageGCST9050237315.76
549FGA levelsGCST9046921615.75
550Phospholipids to Total Lipids in Large VLDL percentageGCST9049825215.71
551Average diameter for HDL particlesGCST9049745415.70
552Triglycerides in very small VLDLGCST9050088515.68
553HDL cholesterol levelsGCST9009282215.67
554Phospholipids in very large HDL (UKB data field 23553)GCST9026965015.65
555Orange juice likingGCST9009480615.64
556Low hand grip strength (60 years and older) (FNIH)GCST9000752915.62
557TNFRSF8/TNFRSF9 ratioGCST9031594015.61
558Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375ECGA00037515.61
559RNF43 levelsGCST9042248215.61
560X-12411 levelsGCST9020049215.61
561Polyunsaturated fatty acids to total fatty acids percentageGCST9050264915.61
562Omega-6 fatty acid levelsGCST9050251415.58
563Ascites (non malignant) (PheCode 572)GCST9047609015.58
564Free cholesterol levels in large VLDLGCST9009287215.58
565Monounsaturated fatty acid levelsGCST9049909415.58
566CD74/TIMD4 ratioGCST9031389615.53
567Triglyceride levels in VLDLGCST9009300315.52
568X-24406 metabolite levelGCST9061678915.51
569PLAUR levelsGCST9047025115.48
570Triglycerides to total lipids ratio in medium VLDLGCST9009292715.47
571Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levelsGCST9006027015.46
572ITGB5/VSIR ratioGCST9031523515.45
573Concentration of large VLDL particles (UKB data field 23495)GCST9026959215.45
574Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376ECGA00037615.44
575Triglycerides to total lipids ratio in very small VLDLGCST9009303915.43
576APOA1 levelsGCST9046833115.43
577Diacylglycerol_36:3_[M+H-H2O]1+ levelsGCST9006018915.42
578DPP4/ITGB1 ratioGCST9031454015.42
579NCS1/NPY ratioGCST9031552715.41
580MMP9 levelsGCST9046992315.37
581F-cheese liking (derived food-liking factor)GCST9009472915.37
582Diacylglycerol_34:2_[M+H-H2O]1+ levelsGCST9006017815.37
583triglyceride (minimum, inv-norm transformed)GCST9047643715.36
584Triglyceride levels in small LDLGCST9009296615.34
585Phospholipids to Total Lipids in Very Large HDL percentageGCST9050047415.33
586Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST9049874715.31
587Cholesterol in Small LDLGCST9049955515.30
588Cholesteryl Esters in Large LDLGCST9049795515.29
589Concentration of very large VLDL particlesGCST9009302315.28
590Omega-6 fatty acids to omega-3 fatty acids ratioGCST9049919415.27
591CDC37/SNAP29 ratioGCST9031393515.26
592ADGRE2 levelsGCST9046823715.26
593Pregnenediol disulfate (C21H34O8S2) levelsGCST9019984015.26
594Osteoporosis | musculoskeletalUKBB0000059815.26
595COLEC12/TNFRSF1A ratioGCST9031418715.22
596CLEC1B/MGLL ratioGCST9031409715.22
597Total fatty acid levelsGCST9050272215.22
598PLAU/PLAUR ratioGCST9031567415.22
599IGSF21 levelsGCST9046953815.21
600Triglycerides in VLDL (UKB data field 23408)GCST9026950515.20
601Total lipids in very large HDL (UKB data field 23552)GCST9026964915.18
602Cholesteryl Esters to Total Lipids in Large HDL percentageGCST9049776315.16
603T1 CAT volume L PlanumPolareGCST9038408615.15
604Cholesterol in medium HDL (UKB data field 23568)GCST9026966515.14
605CD300E/EFNA4 ratioGCST9031379715.14
606Osteoporosis NOS | musculoskeletalUKBB0000059915.13
607Glycoprotein acetyls levelsGCST9049732815.12
608NPL levelsGCST9047007215.12
609CD84/VASH1 ratioGCST9031392015.12
610Dysmenorrheic pain severityGCST00665615.11
611Cholesteryl Esters in HDLGCST9049736815.10
612CSPG4 levelsGCST9046889015.10
613Gout, strict definitionFING0000058815.09
614Phospholipids in medium HDL (UKB data field 23567)GCST9026966415.09
615Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T374ECGA00037415.09
616IBD (strict) with PSCFING0000065715.08
617Phospholipids to total lipids in small LDL percentage (UKB data field 23624)GCST9026972115.05
618CCL18/TFPI ratioGCST9031369115.02
619NOMO1 levelsGCST9047006015.02
620Phospholipids to Total Lipids in Medium HDL percentageGCST9049865315.01
621Cholesterol levels in very small VLDLGCST9050070014.99
622Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST9050035914.98
623Free cholesterol to total lipids ratio in medium HDLGCST9009289714.96
624DNAJA2/HCLS1 ratioGCST9031450214.92
625KIAA0040 levelsGCST9042255214.92
626Total Lipids in Medium LDLGCST9049880614.91
627Triglycerides to Total Lipids in Very Large VLDL percentageGCST9050069214.90
628Cholesteryl Esters in Medium LDLGCST9049873914.90
629Phospholipids in HDLGCST9049743714.89
630rfMRI amplitudes (ICA100 node 15)GCST9000460314.89
631OLR1/PLAUR ratioGCST9031558414.89
632Other noninfective gastroenteritis and colitisFING0000107714.89
633Phospholipids in large VLDL (UKB data field 23497)GCST9026959414.86
634Abnormality of gait (PheCode 350.2)GCST9047584114.86
635Cholesterol to Total Lipids in Very Large HDL percentageGCST9050032414.86
636IDP dMRI TBSS ICVF Cerebral peduncle RGCST9000434114.81
637Phospholipids in small HDL (UKB data field 23574)GCST9026967114.79
638Concentration of very large HDL particles (UKB data field 23551)GCST9026964814.79
639Triglyceride to phosphoglyceride ratioGCST9049999214.78
640Gestational age at birth (maternal effect)GCST9026841914.77
641TAX1BP3 levelsGCST9024297614.77
642Free Cholesterol to Total Lipids in Large VLDL percentageGCST9049820414.77
643Docosahexaenoic acid to total fatty acids percentageGCST9049726814.75
644ENTPD5 levelsGCST9046912114.75
645CLEC4G/SEMA3F ratioGCST9031412314.74
646Disorders of skin appendagesFING0000046014.73
647Total lipids in large VLDLGCST9049821614.73
648Phosphatidylcholine levelsGCST9049924014.71
649Total cholines levelsGCST9049718514.70
650Free cholesterol to total lipids ratio in very small VLDLGCST9009303314.69
651Sleep duration | SleepUKBB0000077714.67
652GOT1 levelsGCST9046937914.67
653Polyunsaturated fatty acid levelsGCST9050214014.66
654Total lipids in very large VLDL (UKB data field 23489)GCST9026958614.65
655CD4/LILRB4 ratioGCST9031384314.65
656Omega-3 fatty acid levelsGCST9050205514.63
657ACP5 levelsGCST9046820314.62
658Triglycerides in small HDLGCST9049951614.62
659Cholesterol esters in very small VLDLGCST9050074014.62
660Free Cholesterol to Total Lipids in IDL percentageGCST9049757914.58
661Triglycerides in medium HDLGCST9049867214.58
662Phospholipids in large VLDLGCST9049824314.58
663Other specified diseases of sebaceous glands (PheCode 706.8)GCST9047621514.57
664CRTAM/KLRD1 ratioGCST9031427714.54
665ALB levelsGCST9049710114.53
666Linoleic acid levelsGCST9049830614.53
667Concentration of very large VLDL particles (UKB data field 23488)GCST9026958514.52
668Cholesterol levels in very large VLDLGCST9050051814.51
669Free cholesterol levels in very large VLDLGCST9009302014.51
670Total lipid levels in medium HDLGCST9009289814.50
671Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604)GCST9026970114.47
672Diastolic blood pressure x sex interactionGCST9033517514.47
673Free cholesterol in large HDLGCST9049778014.46
674Saturated fatty acids levelsGCST9050218614.45
675Total triglycerides levelsGCST9009299214.45
676Total lipids in very large VLDLGCST9050061414.44
677Concentration of very small VLDL particlesGCST9050082614.44
678Docosahexaenoic acid to total fatty acids percentageGCST9050226914.43
679Phospholipids in very small VLDLGCST9050085114.40
680Gout, unspecifiedFING0000058914.40
681Treatment/medication code - omeprazole | MedicationsUKBB0000085214.39
682Total triglycerides levels (UKB data field 23407)GCST9026950414.38
683Triglycerides in very large VLDL (UKB data field 23494)GCST9026959114.38
684Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST9050075414.38
685Phospholipids in large LDLGCST9049805314.37
686Concentration of very large VLDL particlesGCST9050063114.36
687Phospholipids to Total Lipids in IDL percentageGCST9049764214.35
688MMP8 levelsGCST9046992214.34
689CD163/ICAM1 ratioGCST9031373514.34
690GLB1/IMPA1 ratioGCST9031493214.33
691Phospholipid levels in very large VLDLGCST9009302414.30
692IDP dMRI TBSS ICVF Superior cerebellar peduncle RGCST9000433914.27
693ErysipelasFING0000051814.26
694Other chronic obstructive pulmonary disease | Chronic lower respiratory diseasesUKBB0000060414.25
695TriglyceridesGCST9001875514.24
696Free cholesterol to total lipids in IDL percentage (UKB data field 23612)GCST9026970914.24
697Triglycerides in very large HDLGCST9050048214.23
698Triglycerides to Total Lipids in Small LDL percentageGCST9049974014.23
699Concentration of medium HDL particlesGCST9009289914.22
700Total lipids in IDLGCST9049759414.20
701Raw carrot likingGCST9009481814.20
702AXL/GAS6 ratioGCST9031341914.19
703ALDH1A1/PKLR ratioGCST9031324514.18
704Cholesteryl Esters to Total Lipids in IDL percentageGCST9049754914.16
705Cholesteryl esters in very large HDL (UKB data field 23555)GCST9026965214.14
706PKD1 levelsGCST9047024014.14
707Total free cholesterol levelsGCST9050006314.14
708Polyunsaturated fatty acids to total fatty acids percentageGCST9050218114.12
709Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050257014.11
710Phospholipids to Total Lipids in Medium LDL percentageGCST9049885214.10
711CD300C/MANSC1 ratioGCST9031379114.09
712Cholesteryl esters in medium HDL (UKB data field 23569)GCST9026966614.07
713NTRK2 levelsGCST9047009714.06
714Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050207514.06
715Free cholesterol in large VLDL (UKB data field 23500)GCST9026959714.03
716DPP4 levelsGCST9046903314.03
717ALB levelsGCST9009280714.03
718FHIT/PARK7 ratioGCST9031482114.00
719Female infertility, associated with anovulationFING0000053713.99
720Linoleic acid levelsGCST9050201013.99
721Phospholipid levels in chylomicrons and extremely large VLDLGCST9050103113.97
722Triglyceride levels in HDLGCST9009282913.95
723Sphingomyelin_32:1_[M+H]1+ levelsGCST9006022513.95
724Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050206813.94
725Monounsaturated fatty acid levelsGCST9009292813.94
726BTN2A1/LILRB4 ratioGCST9031354613.93
727Triglyceride levels in small HDLGCST9009295413.92
728HYOU1/RARRES2 ratioGCST9031510313.90
729CD74/JAM2 ratioGCST9031389313.90
730GSTA1 levelsGCST9046941113.88
731CD163/FOLR2 ratioGCST9031373413.88
732HNMT/SETMAR ratioGCST9031506913.86
733Cholesteryl esters to total lipids ratio in medium VLDLGCST9009291913.86
734Nontoxic goitre/thyroid noduleFING0000088713.85
735Aspartate aminotransferase levels (UKB data field 30650)GCST9046806313.85
736Saturated fatty acids levelsGCST9050267013.85
737Triglycerides to Total Lipids in Large LDL percentageGCST9049809213.85
738Cholesterol levels in large VLDLGCST9009286813.84
739Phospholipids to total lipids ratio in very large HDLGCST9009301313.83
740Monounsaturated fatty acid levelsGCST9050203013.81
741Concentration of medium LDL particlesGCST9049881913.81
742Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9049928713.79
743Phospholipids in small LDLGCST9049968113.79
744ADGRE5 levelsGCST9046823813.78
745ALCAM/MSR1 ratioGCST9031324013.78
746Osteomyelitis, periostitis, and other infections involving bone (PheCode 710)GCST9047622013.78
747Concentration of medium HDL particlesGCST9049862213.78
748Degree of unsaturationGCST9050016213.77
749Cholesterol to total lipids ratio in very small VLDLGCST9009302913.77
750HCLS1/LAT ratioGCST9031504113.76
751Apple juice likingGCST9009469013.75
752Triglycerides to Total Lipids in Small HDL percentageGCST9049953013.74
753ENPP5 levelsGCST9046911613.74
754Oily fish intake | DietUKBB0000054713.74
755Triglyceride levels in medium LDLGCST9009291413.71
756Cholesterol to Total Lipids in IDL percentageGCST9049751813.68
757Total fatty acid levelsGCST9050221213.67
758Triglycerides to Total Lipids in Medium VLDL percentageGCST9049907313.64
759Polyunsaturated fatty acid levelsGCST9009293913.64
760triglyceride (maximum, inv-norm transformed)GCST9047642913.63
761Triglycerides to Total Lipids in Very Large VLDL percentageGCST9050069513.63
762Saturated fatty acids levelsGCST9050219213.62
763Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST9050094313.62
764Monounsaturated fatty acids to total fatty acids percentageGCST9049911113.62
765CDKN1A/FOXO1 ratioGCST9031397013.61
766Monounsaturated fatty acids to total fatty acids percentageGCST9049910913.61
767APOE levelsGCST9046833813.61
768Cardiovascular diseaseGCST9008605713.60
769LRTM2 levelsGCST9046980813.59
770CCDC80/CCL27 ratioGCST9031366913.58
771Cake icing likingGCST9009472313.58
772IDP SWI T2star right pallidumGCST9000387013.56
773Lysoalkylphosphatidylcholine (O-24:2) levelsGCST9002543813.54
774Triglycerides to Total Lipids in Medium VLDL percentageGCST9049906913.53
775Phospholipids in small VLDLGCST9049988113.53
776Free cholesterol to total lipids ratio in very large VLDLGCST9009302113.52
777APOC1 levelsGCST9046833613.52
778Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST9050059813.50
779Memory loss or impairmentGCST9047554413.49
780Cholesterol to Total Lipids in Medium VLDL percentageGCST9049891913.49
781Cholesterol levels in very large VLDLGCST9009301613.49
782Cholesteryl Esters in Small LDLGCST9049957813.48
783Triglycerides to Total Lipids in Large LDL percentageGCST9049810113.48
784Free cholesterol to total lipids ratio in medium VLDLGCST9009292113.48
785CD302/CD99 ratioGCST9031380513.47
786Cholesterol in Medium LDLGCST9049870713.47
787Cholesteryl esters in very large VLDLGCST9050055213.46
788Phospholipid levels in medium HDLGCST9009290013.45
789DCBLD2/PLA2G15 ratioGCST9031442813.45
790Omega-3 fatty acids to total fatty acids percentageGCST9049916313.45
791Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | MedicationUKBB0000045613.43
792Phospholipids to Total Lipids in Very Large VLDL percentageGCST9050066513.43
793Total lipids in small HDLGCST9049944313.42
794Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST9049934013.39
795Free cholesterol to total lipids ratio in large LDLGCST9009286113.39
796Diacylglycerol_34:1_[M+H-H2O]1+ levelsGCST9006017913.38
797FCAR/LY96 ratioGCST9031478813.38
798Ratio of triglycerides to phosphoglyceridesGCST9009298313.37
799Saturated fatty acids to total fatty acids percentageGCST9050220713.35
800Principal component-derived dietary pattern 13GCST9013301813.34
801HPCAL1/LAT ratioGCST9031507213.34
802Cardiorespiratory fitness slopeGCST9009331913.34
803T1 FreeSurfer pial rh lateraloccipital areaGCST9038583213.33
804Obstructive chronic bronchitis | respiratoryUKBB0000054613.33
805RARRES2 levelsGCST9047042813.33
806Cholesteryl ester levels in HDLGCST9009282313.33
807SNX2 levelsGCST9047070113.33
808Left-hemisphere visual network to accumbens white-matter structural connectivityGCST9030266813.31
809IFNAR1 levelsGCST9046951213.31
810CHI3L1/PRSS8 ratioGCST9031404413.30
811HPCAL1/MPIG6B ratioGCST9031507313.28
812Phospholipids in very large HDLGCST9050045813.27
813Free cholesterol in small VLDLGCST9049980813.25
814Triglycerides in VLDLGCST9050030413.24
815Cholesterol to total lipids in large LDL percentage (UKB data field 23615)GCST9026971213.24
816Oily fish consumptionGCST9013299313.23
817APOB levelsGCST9049713713.18
818ALB levelsGCST9047510013.18
819DUT levelsGCST9046905413.17
820Triacylglycerol_51:3_[M+NH4]1+ levelsGCST9006049413.17
821NELL2 levelsGCST9047002713.14
822Free cholesterol in very small VLDLGCST9050077413.14
823Triglycerides in HDLGCST9049746713.14
824Triglyceride to phosphoglyceride ratioGCST9049999613.12
825Left-hemisphere default mode network to left-hemisphere default mode network white-matter structural connectivityGCST9030275913.11
826Total cholesterol minus HDL-C levelsGCST9049912913.11
827Cholesterol in very large HDL (UKB data field 23554)GCST9026965113.10
828CCL17/THPO ratioGCST9031368913.10
829LAT2/SERPINB1 ratioGCST9031527913.10
830Sphingomyelin_34:0_[M+H]1+ levelsGCST9006024113.08
831Triglycerides in IDLGCST9049766113.07
832Total lipids in large VLDLGCST9049820713.07
833ALDH1A1/CA3 ratioGCST9031324413.07
834MMP8/TGFA ratioGCST9031546613.06
835KIFBP/LYN ratioGCST9031524613.06
836Cholesteryl Esters to Total Lipids in Small LDL percentageGCST9049959513.04
837Cholesteryl esters to total lipids ratio in very small VLDLGCST9009303113.04
838Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levelsGCST9006031813.03
839Cholesterol levels in very large HDLGCST9050032213.02
840Phospholipids in very small VLDLGCST9050084013.01
841Polyunsaturated fatty acids levels (UKB data field 23446)GCST9026954312.99
842ASAH2 levelsGCST9024209812.99
843ALB levelsGCST9026957612.99
844Phosphoglycerides levelsGCST9049925912.99
845IDP T1 FAST ROIs L cerebellum I-IVGCST9000256212.98
846Omega-3 fatty acids to total fatty acids percentageGCST9049915512.98
847BTN2A1/SMOC2 ratioGCST9031354912.97
848Activities undertaken to treat anxiety | AnxietyUKBB0000000912.97
849LGALS3BP levelsGCST9046976012.96
850Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050241112.95
851CRKL/MANF ratioGCST9031426912.95
852Triglycerides to Total Lipids in Small LDL percentageGCST9049972612.94
853Ratio of monounsaturated fatty acids to total fatty acidsGCST9009292912.94
854Concentration of large LDL particlesGCST9049803712.93
855C2 levelsGCST9046849712.93
856Phospholipids in IDLGCST9049762812.91
857Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARBUKBB0000069012.90
858LRP11/ROR1 ratioGCST9031533012.88
859CST3/DEFA1_DEFA1B ratioGCST9031429112.87
860PTPN1/TDRKH ratioGCST9031574512.87
861Left ventricular end systole anterolateral wall thicknessGCST9027851112.87
862DNAJA2/HPCAL1 ratioGCST9031450312.87
863Linoleic acid to total fatty acids percentage (UKB data field 23456)GCST9026955312.87
864Cholesteryl ester_18:1_[M+NH4]1+ levelsGCST9006022112.85
865Cholesteryl Esters in Small HDLGCST9049938612.85
866Triglycerides to total lipids ratio in very large HDLGCST9009301512.85
867CDKN1A/PLA2G4A ratioGCST9031397412.84
868Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST9026953212.84
869Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050206912.82
870CD4 levelsGCST9046863612.82
871Aspartate aminotransferase | Blood biochemistryUKBB0000005212.81
872HSD17B14 levelsGCST9046948312.81
873CDKN1A/NCK2 ratioGCST9031397312.79
874C20:4 Lysophosphatidylcholine levels in chronic kidney diseaseGCST9025757012.79
875Triglycerides in medium LDLGCST9049887012.78
876Cholesteryl Esters in Large VLDLGCST9049815412.77
877CCN2/MGLL ratioGCST9031371412.76
878Total phospholipids in lipoprotein particles (UKB data field 23411)GCST9026950812.76
879NRAC levelsGCST9061799112.76
880CXCL17/SFTPA2 ratioGCST9031434112.76
881Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)GCST9026969312.75
882Urine methylsuccinoylcarnitine levels in chronic kidney diseaseGCST9026550912.75
883CALCOCO1/TJAP1 ratioGCST9031361112.73
884Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)GCST9026955112.72
885Free Cholesterol to Total Lipids in Small HDL percentageGCST9049943612.71
886Cholesterol to Total Lipids in Small HDL percentageGCST9049937312.71
887Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | MedicationUKBB0000045512.70
888Insomnia (weighted GWA)GCST9026728712.70
889Diacylglycerol_44:7_[M+H-H2O]1+ levelsGCST9006024012.70
890GLB1 levelsGCST9046935512.69
891Phosphatidylethanolamine (18:0_18:1) levelsGCST9002497712.68
892Cholesteryl ester levels in very large VLDLGCST9009301812.67
893Total lipid levels in medium VLDLGCST9009292212.66
894aparc-a2009s rh area G+S-subcentralGCST9000337412.65
895Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050095812.65
896Omega-6 fatty acids to total fatty acids percentageGCST9050254512.63
897CLEC4G/NELL2 ratioGCST9031412212.63
898Free cholesterol in large VLDLGCST9049818512.62
899Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T378ECGA00037812.62
900Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363ECGA00036312.62
901Ratio of linoleic acid to total fatty acidsGCST9009288112.62
902Lysoalkylphosphatidylcholine (O-24:1) levelsGCST9002481312.61
903Lysoalkylphosphatidylcholine (O-24:1) levelsGCST9002419812.61
904NAGA levelsGCST9046999412.60
905ASPN levelsGCST9046837712.60
906Cholesterol, totalGCST00076012.58
907OLR1 levelsGCST9047012212.57
908CRADD/STAMBP ratioGCST9031424412.56
909Total triglycerides levelsGCST9050012612.56
910Phospholipids in very large VLDL (UKB data field 23490)GCST9026958712.55
911Cholesteryl esters to total lipids ratio in large VLDLGCST9009287112.55
912Phospholipids to total lipids in large HDL percentage (UKB data field 23634)GCST9026973112.55
913PLA2G15 levelsGCST9047024512.54
914COL6A3/SMOC2 ratioGCST9031417812.54
915Principal component-derived dietary pattern 58GCST9013306112.54
916Phospholipids in very large VLDLGCST9050064412.53
917Monounsaturated fatty acids to total fatty acids percentageGCST9050238412.53
918Monounsaturated fatty acid levelsGCST9050203612.52
919Total lipid levels in lipoprotein particlesGCST9009298912.52
920Cholesterol esters in very large HDLGCST9050034412.51
921Cholesterol esters in very large HDLGCST9050035412.51
922S100P levelsGCST9047052012.50
923Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST9050056912.50
924BCAN/MOG ratioGCST9031348012.49
925RILP/RWDD1 ratioGCST9031577812.48
926Concentration of LDL particlesGCST9049841312.48
927Omega-6 fatty acid levelsGCST9009293312.47
928Total lipid levels in VLDLGCST9009299912.45
929MAD1L1 levelsGCST9046983612.44
930Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)GCST9026969212.44
931Phospholipids to total lipids ratio in small LDLGCST9009296512.43
932CD244/TREML2 ratioGCST9031376712.43
933ESAM/VSIR ratioGCST9031472112.42
934Concentration of small VLDL particlesGCST9049985612.42
935HAVCR2 levelsGCST9046943212.40
936EIF4G1/HEXIM1 ratioGCST9031463512.37
937Free cholesterol to total lipids ratio in small VLDLGCST9009297312.37
938Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364ECGA00036412.34
939Cholesterol in IDLGCST9049750112.34
940Free cholesterol in very large HDLGCST9050038012.32
941Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050255512.32
942Triglyceride to HDL cholesterol ratioGCST9029595112.32
943Phospholipids in IDLGCST9049762612.31
944Alzheimer's disease or family history of Alzheimer's diseaseGCST9001287712.30
945ADA2 levelsGCST9046821512.30
946Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050105012.30
947Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T377ECGA00037712.29
948Triglycerides to Total Lipids in IDL percentageGCST9049768212.29
949SRC/STAT5B ratioGCST9031588212.28
950Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)GCST9026972312.27
951Triglycerides in small HDLGCST9049951912.26
952Sphingomyelins levelsGCST9049997212.26
953RHOC/TBCC ratioGCST9031577512.25
954Total fatty acid levelsGCST9050221812.24
955MANF/PDGFB ratioGCST9031536012.23
956Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levelsGCST9006042012.22
957Androstenediol (3beta,17beta) disulfate (1) levelsGCST9019984212.21
958Cholesterol in Large VLDLGCST9049811912.21
959Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050109112.20
960Phospholipids in large HDLGCST9049784712.19
961Total lipids in medium HDLGCST9049860412.18
962Low-density lipoprotein levels (MTAG)GCST9017914812.17
963BAIAP2 levelsGCST9046841912.17
964BIN2/EREG ratioGCST9031350312.16
965PON3 levelsGCST9047028712.16
966FXN/TRIAP1 ratioGCST9031489912.15
967CD84/DKK1 ratioGCST9031391112.14
968Triglyceride levels in very small VLDLGCST9013266912.11
969Triacylglycerol_53:2_[M+NH4]1+ levelsGCST9006053112.10
970Total lipids in small VLDLGCST9049984012.10
971Polyunsaturated fatty acid levelsGCST9050214212.09
972Free cholesterol in large LDLGCST9049798112.08
973SERPINF2 levelsGCST9047059912.08
974CTSS levelsGCST9046891612.07
975Cholesteryl Esters in LDLGCST9049837412.06
976Omega-6 fatty acid levelsGCST9050209512.06
977Cholesterol to total lipids ratio in very large VLDLGCST9009301712.05
978ANGPTL2 levelsGCST9046830312.04
979Modified Stumvoll Insulin Sensitivity IndexGCST9026757412.03
980CCL18/RARRES2 ratioGCST9031369012.02
981CDKN1A/TMSB10 ratioGCST9031397812.01
982CASP3/CRKL ratioGCST9031363112.01
983Total Alkenylphosphatidylcholine levelsGCST9002583512.00
984Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST9009304211.99
985HGF/MMP9 ratioGCST9031505611.98
986Triglycerides to Total Lipids in Small VLDL percentageGCST9049993411.98
987Triglycerides in very large HDLGCST9050048111.98
988VSTM2B levelsGCST9047105611.97
989Cholesterol to Total Lipids in Very Large VLDL percentageGCST9050053911.97
990Triglycerides in large HDLGCST9049788811.97
991CCL5/LAMA4 ratioGCST9031370311.96
992Omega-3 fatty acid levelsGCST9050242511.95
993Docosahexaenoic acid levelsGCST9050197811.95
994C-reactive protein | Blood biochemistryUKBB0000011311.95
995Free cholesterol in very large VLDL (UKB data field 23493)GCST9026959011.94
996FBP1 levelsGCST9046919511.91
997Polyunsaturated fatty acids to total fatty acids percentageGCST9050263311.91
998FUT8/VEGFC ratioGCST9031489611.91
999Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050092011.90
1000MMP1/SERPINB6 ratioGCST9031546211.89